* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Management of Acute Myocardial Infarction
Survey
Document related concepts
Transcript
Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION Diagnosis of MI (WHO definition) is based on the presence of at least 2 of the following 3 criteria: 1. A clinical history of ischaemic-type chest discomfort 2. Changes on serially obtained ECG tracings 3. A rise and fall in serum cardiac markers Aim of initial management 1. Identify true ST-elevation infarcts early 2. Provide early aggressive reperfusion 3. Monitor for complications of AMI (cardiogenic shock, APO, arrhythmias) Note: thrombolytic therapy is highly effective in patients with ST elevation or presumably new LBBB (obscures the ECG diagnosis of MI). However, thrombolytic therapy is ineffective and possibly even harmful in unstable angina (ST depression presentation) and non-ST-elevation MI (NSTEMI) Patients who are referred to the ICU with AMI invariably have complications as a direct result of the MI or have other conditions warranting ICU care (eg. concurrent sepsis, other organ dysfunction, peri-operative AMI requiring a period of observation) General measures • Oxygen therapy • Pain relief • Avoid valsalva manoeuvres • Select ECG monitoring based on infarct location and rhythm Investigations and Monitoring • 12-lead ECG done on presentation or ICU admission. Non-diagnostic ECG should be repeated at 15-30 min interval followed by every 6 hourly for the first 24 hours of admission • 2 sets of cardiac Troponin T. First set should be done on presentation and if normal, do 2nd set at > 6 hours apart • CPK daily for 3 days • Other routine bloods including clotting profile • CXR • Intra-arterial pressure monitoring • CVP if haemodynamic iunstable or need inotropic agents or vasopressors • Indications fo Swan Ganz – severe or progressive CHF or pulmonary oedema; cardiogenic shock or progressive hypotension; suspected mechanical complications of acute infarction ie VSD, papillary muscle rupture or pericardial tamponade Page 1 of 5 Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong Drug therapy Aspirin – give stat 320 mg on day of AMI. Then 160 mg daily Nitroglycerin Indications For first 24-48 hours in patients with Ami and CHF, large anterior infarction, persistent ischaemia or hypertension Continued use beyond 48 hours in patients with recurrent angina or persistent pulmonary congestion Contraindications Initial systolic BP < 90 mmHg Marked bradycardia (< 50bpm) or tachycardia Suspected RV infarction Thrombolysis – see below for more details Heparin Indications IV unfractionated heparin (UH) for patients post thrombolysis with rt-PA – see PWH thrombolysis protocol IV UH for patients undergoing primary percutaneous coronary intervention (PCI) LMWH SC for patients with NSTEMI (enoxaparine 1 mg/kg bd) not given thrombolysis and with no contraindications to heparin Beta-blockers Indications Start within 12 hours post AMI if no contraindication irrespective of concomitant thrombolysis or primary PCI Continuing or recurrent ischaemic pain Tachyarrhythmias, eg rapid AF NSTEMI ACEI Indications Within first 24 hours of a suspected AMI with clinical heart failure in absence of hypotension (SBP>100 mmHg) AMi with LV ejection fraction < 40% or patients with clinical heart failure during and after convalescence from AMI Statins Evidence show that starting statin early (eg atorvastatin) beneficial. Can start even when patient still in ICU Intra-aortic Balloon Counterpulsation Indications for placement 1. Cardiogenic shock not quickly reversed with pharmacological therapy as a stabilizing measure for angiography and prompt revascularization Page 2 of 5 Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong 2. Acute mitral regurgitation or VSD complicationg MI as a stabilizing therapy for angiography and repair/revasculariztion 3. Recurrent intractable ventricular arrhythmias with haemodynamic instability 4. Refractory post-MI angina as a bridge to angiography and revascularization Consult cardiologist for all patients requiring IABP. However, in our unit, if patients are going for prompt surgical revascularization or if patient belongs to the cardiac surgical unit, the cardiac surgeons will insert the IABP. Thrombolysis Decision for thrombolysis should be discussed with the on-call ICU senior and oncall cardiologist Who should be thrombolysed? • Typical chest pain lasting more than 30 minutes • ST elevation (greater than 0.2 mV, in 2 or more contiguous leads), </= 12 hours from AMI, age between 21 and 75 years (age >75 years, overall risk of mortality is high with or without therapy. Relative benefit of therapy is reduced. However, can still be considered on individual basis) • LBBB and history suggesting AMI • Benefit less for inferior AMI, except for subgroup of RV infarction (ST elevation RV-4) or anterior-segment depression indicative of a posterior current of injury (occlusion of a large circumflex coronary artery) PWH CCU Guidelines on thrombolysis Which thrombolytic regimens? 1. Streptokinase 1.5 million units in 100 mls NS infused over 1 hour 2. Accelerating rt-PA (more effective, but more expensive and carry more risk of intracranial haemorrhage) 15 mg bolus 0.75 mg/kg over 30 mins (max 50mg) 0.5 mg/kg over next 60 mins (max 35 mg) Total dose <100 mg IV heparin (4000 units IVI bolus at the 3rd hour ie 1 and ½ hours after completion of rt-PA; keep ACT < 300, then 800 units /hour to keep APTT 2x control or 60-85 seconds for 48 hours) Who should not be given thrombolysis (but fulfill criteria for thrombolysis)? • Pregnant patient • Currently menstruating Page 3 of 5 Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong • • Post-traumatic CPR Known bleeding disorders (CVA < 3 months, history of intracerebral hemorrhage, GU bleeding < 3 months, other bleeding tendency…, on warfarin) • Recent brain or abdominal surgery within 2 weeks • Active pancreatitis • Uncontrolled hypertension BP > 200/100 mmHg • Diabetic retinopathy • Aortic dissection • Clotting time > 9 minutes How would you know if thrombolysis is effective? Some indications from 1. free of chest pain 2. ECG normalized 3. Early flush of cardiac enzymes 4. Reperfusion arrhythmia Management of complications from Acute Myocardial Infarction Left ventricular dysfunction with (see chapter on management of heart failure) Acute pulmonary oedema – oxygenate, diuresis, GTN, ACEI Cardiogenic shock – noradrenaline, dobutamine, IABP, PCI or CABG Arrhythmias (see relevant chapter) Vast majority of post MI VT and VF occur within the first 48 hours of MI. Right ventricular infarction and dysfunction Deserves some mention as RV infarction accompanying inferior MI is associated with a significantly higher mortality (25 – 30 % To diagnose: demonstrate 1 mm ST segment elevation in right precordial lead V4R Management: Avoid nitrates and diuretics Volume loading Initiate inotropic support (dobutamine) promptly if cardiac output fails to improve after 0.5 to 1 litre of fluid Maintain AV synchrony – cardiovert AF Thrombolytic therapy, PCI Page 4 of 5 Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong Acute Coronary Symdromes Ischaemic Discomfort ST Elevation No ST Elevation Unstable Angina Non Q-wave MI Page 5 of 5 Q-wave MI Q-wave MI Non-Q-wave M